Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,913 | 5 | 71.7% |
| Food and Beverage | $7,403 | 336 | 28.1% |
| Education | $55.29 | 3 | 0.2% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Micro-tech Endoscopy USA, Inc. | $17,537 | 7 | $0 (2022) |
| ABBVIE INC. | $1,821 | 94 | $0 (2024) |
| Ardelyx, Inc. | $1,661 | 3 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $1,256 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $522.78 | 40 | $0 (2024) |
| Braintree Laboratories, Inc. | $241.38 | 13 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $206.51 | 18 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $195.65 | 3 | $0 (2024) |
| Medtronic, Inc. | $173.74 | 2 | $0 (2021) |
| INTERCEPT PHARMACEUTICALS, INC. | $172.30 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $993.49 | 42 | ABBVIE INC. ($329.81) |
| 2023 | $1,192 | 41 | ABBVIE INC. ($287.27) |
| 2022 | $12,626 | 54 | Micro-tech Endoscopy USA, Inc. ($9,625) |
| 2021 | $655.55 | 17 | Janssen Scientific Affairs, LLC ($230.49) |
| 2020 | $82.28 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($22.56) |
| 2019 | $706.41 | 30 | Janssen Scientific Affairs, LLC ($229.80) |
| 2018 | $2,591 | 78 | Micro-tech Endoscopy USA, Inc. ($1,400) |
| 2017 | $7,524 | 81 | Micro-tech Endoscopy USA, Inc. ($6,498) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/17/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Immunology | ||||||
| 06/11/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $105.39 | General |
| 05/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/28/2024 | Janssen Scientific Affairs, LLC | STELARA (Biological), REMICADE, TREMFYA | Food and Beverage | In-kind items and services | $124.75 | General |
| Category: Immunology | ||||||
| 05/23/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 563 | 577 | $427,768 | $78,120 |
| 2022 | 9 | 591 | 621 | $432,051 | $72,102 |
| 2021 | 13 | 617 | 642 | $422,504 | $76,776 |
| 2020 | 10 | 533 | 551 | $343,588 | $62,496 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 234 | 236 | $251,812 | $47,982 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 53 | $15,529 | $6,542 | 42.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 26 | 26 | $20,231 | $4,612 | 22.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 80 | 85 | $57,800 | $4,425 | 7.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 45 | $9,765 | $4,297 | 44.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 52 | 52 | $44,044 | $3,883 | 8.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 22 | 25 | $16,225 | $2,070 | 12.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,312 | $1,943 | 36.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,942 | $1,200 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 21 | $3,108 | $1,167 | 37.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 181 | 184 | $196,328 | $36,216 | 18.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 47 | 56 | $16,408 | $6,934 | 42.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 122 | 131 | $85,790 | $6,506 | 7.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 33 | 33 | $25,680 | $5,837 | 22.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 67 | 69 | $58,443 | $4,894 | 8.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 39 | 45 | $29,205 | $3,967 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 44 | $9,548 | $3,718 | 38.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $5,913 | $2,036 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 32 | $4,736 | $1,994 | 42.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 191 | 193 | $205,931 | $38,777 | 18.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 31 | 31 | $24,118 | $5,598 | 23.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 104 | 112 | $65,632 | $5,480 | 8.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 33 | $9,669 | $4,783 | 49.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 42 | $9,114 | $3,976 | 43.6% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 31 | 36 | $23,364 | $3,544 | 15.2% |
About Dr. David Levitan, M.D
Dr. David Levitan, M.D is a Gastroenterology healthcare provider based in Southlake, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699751065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Levitan, M.D has received a total of $26,370 in payments from pharmaceutical and medical device companies, with $993.49 received in 2024. These payments were reported across 348 transactions from 41 companies. The most common payment nature is "Consulting Fee" ($18,913).
As a Medicare-enrolled provider, Levitan has provided services to 2,304 Medicare beneficiaries, totaling 2,391 services with total Medicare billing of $289,494. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Southlake, TX
- Active Since 12/19/2005
- Last Updated 05/23/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1699751065
Products in Payments
- IBSRELA (Drug) $1,661
- STELARA (Biological) $1,633
- Balloons (Device) $1,400
- RINVOQ (Biological) $584.66
- Humira (Biological) $450.06
- SKYRIZI (Biological) $315.69
- ZEPOSIA (Drug) $295.81
- GI Genius (Device) $173.74
- OCALIVA (Drug) $172.30
- Alinia Tablets 500mg 30 count bottle (Drug) $163.78
- XIFAXAN (Drug) $155.24
- HUMIRA (Biological) $149.62
- LINZESS (Drug) $138.55
- REMICADE (Biological) $129.44
- DIFICID (Drug) $129.24
- SUTAB (Drug) $125.12
- Viekira (Drug) $117.22
- SUPREP (Drug) $116.26
- INJECTAFER (Drug) $110.68
- LINX Reflux Management System (Device) $109.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Southlake
Dr. Timothy Ritter, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. James Weber, M.d, M.D
Gastroenterology — Payments: $17,582
Dr. David Spady, M.d, M.D
Gastroenterology — Payments: $12,464
Dr. Stephen Lacey, M.d, M.D
Gastroenterology — Payments: $5,636
Dr. Jeffrey Smith, M.d, M.D
Gastroenterology — Payments: $5,235
Dr. Azaan Ramani, Do, DO
Gastroenterology — Payments: $4,793